Media Summary: Felicitas Thol, MD, Hannover Medical School, Hannover, Germany, discusses the use of Eric Solary, MD, Gustave Roussy Institute, Paris, France, outlines currently used Rafael Bejar, MD, PhD, UC San Diego Moores Cancer Center, San Diego, CA, discusses the characteristic
Prognostic Factors And Mutations In Mds - Detailed Analysis & Overview
Felicitas Thol, MD, Hannover Medical School, Hannover, Germany, discusses the use of Eric Solary, MD, Gustave Roussy Institute, Paris, France, outlines currently used Rafael Bejar, MD, PhD, UC San Diego Moores Cancer Center, San Diego, CA, discusses the characteristic James M. Foran, MD, FRCP, and Azra Raza, MD, explain how Michaela Fontenay, MD, PhD, Cochin Hospital, Paris, France, comments on the impact of SF3B1 Dr. Rami Komrokji, from Moffitt Cancer Center, will provide an overview of recent advances in the genetic understanding of
Genomic sequencing studies are needed to gain a deeper understanding of the pathogenesis of myeloid malignancies. Rami Komrokji, MD, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, discusses the new World Health ... Eytan Stein, MD, Memorial Sloan Kettering Cancer Center, New York City, NY, comments on the Dr. Jamile Shammo, Rush University Medical Center, will provide an overview of Moshe Mittelman, MD, Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel, outlines the key points from his talk ... Uwe Platzbecker, MD, University of Leipzig, Leipzig, Germany, offers insight into the effects of genetics on inflammatory states in ...
A roundtable discussion, moderated by Amer Zeidan, MBBS, MHS, of Yale University, focused on the latest updates in the care of ... Webinar lead by Dr Michelle Geddes on January 18, 2022 Dr. Michelle Geddes, FRCPC Learning objectives: Not all
